Vantive Health LLC

Vantive Health LLC is an American healthcare company focused on vital organ therapies, with a particular emphasis on kidney care and acute organ support. The company describes itself as "a newly independent healthcare company focused on vital organ therapies," and states that it separated from Baxter in 2025. Its stated purpose is "Extending Lives >>> Expanding Possibilities," and it positions itself as a partner to clinicians and patients across the dialysis and intensive care journeys. Vantive's product and service portfolio centers on dialysis and organ support. The company says it has built a legacy of exceptional kidney care products over seven decades, and that it is now deepening its commitment to elevating the dialysis experience through digital solutions and advanced services while evolving its organ support therapies beyond kidney care. Its offerings include peritoneal dialysis (PD) solutions, automated peritoneal dialysis (APD) systems, continuous renal replacement therapy (CRRT) products, and therapies such as PrismaLung+ used in acute care settings. The company also highlights health economic evidence and clinical data around home dialysis and HDx therapy. Vantive operates globally, with regional leadership for the Americas, Asia-Pacific, Europe, Middle East and Africa, and China. Its management team is led by Chief Executive Officer Chris Toth, alongside executives covering finance, business, people, legal, transformation, information, strategy, and regional and product leadership roles. The company has announced operational expansions, including a new Vancouver-area distribution facility intended to strengthen supply chain performance for healthcare providers. As a standalone company, Vantive presents itself as having "purity of focus," dedicating every idea and innovation to the advancement of vital organ care while prioritizing the needs of patients and clinicians. It emphasizes quality and regulatory affairs, and it offers grants, sponsorships and funding opportunities to collaborate with healthcare institutions and innovators. The company's global history page traces industry firsts such as the first commercial dialysis system in 1956, the first peritoneal dialysis solution in 1960, and the first CAPD system in the United States in 1979, through to the acquisition of GAMBRO AB in 2013.

Vantive Health LLC describes itself as a newly independent healthcare company that separated from Baxter in 2025, building on a 70-year legacy as a leader in kidney care innovation. The company's global history page traces its lineage through a series of industry firsts in dialysis and organ support. In 1956, building on the groundbreaking work of Dutch physician Willem Kolff, who developed the first "artificial kidney" made from wood slats, orange juice cans and a cellophane membrane, the organization produced the first commercial dialysis system. In 1960, it introduced the first peritoneal dialysis (PD) solution, which filters waste from the blood of people in kidney failure through their peritoneal membrane rather than an external dialyzer. In 1979, it introduced to the U.S. market the first CAPD system, which included solution bags, tubing with a spike at one end, a titanium luer lock to connect to the patient's catheter, and an antiseptic solution to clean the spike/bag connection. The company expanded its global presence and innovations in the 1990s. In 1994, it launched the Homechoice APD System, an automated peritoneal dialysis (APD) system designed to make it easier for PD patients to perform treatments in their homes as well as away from home. Also in 1994, it opened a plant in Singapore to make PD solutions for the Asian market. In the new millennium, the company developed Extraneal (icodextrin), a non-glucose-based PD solution, in 2003. In 2013, it acquired GAMBRO AB, described as a highly respected global innovator in kidney care. In 2015, the history page references a further milestone (the snippet is truncated). In 2025, Vantive separated from Baxter to become a standalone company dedicated to advancing vital organ therapies. As an independent entity, Vantive states that it is deepening its commitment to elevating the dialysis experience through digital solutions and advanced services while evolving its organ support therapies to go beyond kidney care. The company emphasizes greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients. It operates globally with regional presidents for the Americas, Asia-Pacific, Europe, Middle East and Africa, and China, and has announced operational expansions such as a new Vancouver-area distribution facility.

• 2026

  Announced a new Vancouver-area distribution facility to strengthen supply chain performance.

• 2025

  Separated from Baxter to become a standalone company dedicated to advancing vital organ therapies.

• 2015

  Further milestone referenced in global history (details truncated in source).

• 2013

  Acquired GAMBRO AB, a global innovator in kidney care.

• 2003

  Developed Extraneal (icodextrin), a non-glucose-based PD solution.

• 1994

  Launched the Homechoice APD System and opened a plant in Singapore to make PD solutions for the Asian market.

• 1979

  Introduced to the U.S. market the first CAPD system.

• 1960

  Introduced the first peritoneal dialysis (PD) solution.

• 1956

  Produced the first commercial dialysis system.

A vital partner driving meaningful change through therapies, digital solutions and advanced services that empower clinicians and patients in vital organ care.

• Homechoice APD System

  Automated peritoneal dialysis (APD) system launched in 1994, making it easier for PD patients to perform treatments at home and away from home.

• Extraneal (icodextrin) PD solution

  A non-glucose-based PD solution developed in 2003.

• PrismaLung+

  Used in acute care, including ECCO₂R in mild-to-moderate ARDS.

• HDx therapy

  Presented as a practical alternative to online hemodiafiltration based on late-breaking data at ERA.

• CRRT products

  Continuous renal replacement therapy products for acute care.

1. 1Introducing Vantive | Vantive: Extending Lives and Expanding Possibilitiesvantive.com
2. 2Explore Vantive's Global History of Vital Organ Care Innovation | Vantive: Extending Lives and Expanding Possibilitiesvantive.com
3. 3Vantive Kidney Care and Acute Organ Support | Vantive: Extending Lives and Expanding Possibilitiesvantive.com
4. 4Meet the Vantive Management Team| Vantive: Extending Lives and Expanding Possibilitiesvantive.com
5. 5Vantive Health LLCwikidata.org